Representative before the EPO

Employment test 51 - 200 employees
Company dna potter clarkson llp
operating since 1889
Headquarter in Nottingham and 1 office
active in Legal Services, IP Consulting, and IP Portfolio Processing

We have observed 4 EP applications Philip John Duval Thomas has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after February 20, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12196192

Mutant G-protein coupled receptors and methods for making them

IPC classification:
C07K 14/72, C12N 15/10, G01N 33/566
Agent:
Philip John Duval Thomas, Potter Clarkson LLP
Status:
EXAMINATION IN PROGRESS
EP12192130

Screening

IPC classification:
C07K 14/705, C12N 15/10, G01N 33/543, G01N 33/566
Agent:
Philip John Duval Thomas, Potter Clarkson LLP
Status:
EXAMINATION IN PROGRESS
EP12718715

RE-DIRECTED IMMUNOTHERAPY

IPC classification:
A61K 39/12, A61K 47/48, A61P 37/00
Applicant:
University of Birmingham
Agent:
Philip John Duval Thomas, Potter Clarkson LLP
Status:
PATENT GRANTED
EP12819805

METHODS, COMPOSITIONS AND KITS FOR ASSAYING MITOCHONDRIAL FUNCTION

IPC classification:
C12Q 1/00, C12Q 1/26, C12Q 1/32
Applicant:
University of Massachusetts
Agent:
Philip John Duval Thomas, Potter Clarkson LLP
Status:
PATENT GRANTED

Please Sign in to use this feature